Vaxin's Unattributed VC - II Round

Vaxin raised a round of funding on February 17, 2015.

Altimmune, formerly Vaxin, is a clinical stage immunotherapeutic biotechnology company focused on the discovery and development of novel products that engage, stimulate and improve immune responses fo…

Articles about Vaxin's Unattributed VC - II Round: